Paroxysmal Supraventricular Tachycardia: USMLE Guide

High-yield USMLE review of paroxysmal supraventricular tachycardia: mechanisms, ECG clues, diagnosis, acute management, pitfalls, and exam pearls.

Introduction

Paroxysmal supraventricular tachycardia, or **PSVT**, is a sudden-onset, sudden-termination tachycardia that originates **above the ventricles** and is typically **regular** and **narrow-complex** on ECG. For exam purposes, think of an episodic rhythm that often runs in the **150-250 beats/min** range and is most commonly driven by a **reentrant circuit** involving the AV node or adjacent tissue. (pubmed.ncbi.nlm.nih.gov)

The most important subtype to recognize is **AV nodal reentrant tachycardia (AVNRT)**, the most common form of PSVT. Other mechanisms include **AV reentrant tachycardia (AVRT)** using an accessory pathway, as in Wolff-Parkinson-White syndrome, and **atrial tachycardia** arising from an ectopic atrial focus. (pubmed.ncbi.nlm.nih.gov)

For USMLE-style questions, PSVT is classic when a young or otherwise healthy patient reports abrupt palpitations, the ECG shows a **regular narrow-complex tachycardia**, and the rhythm stops with **vagal maneuvers** or **adenosine**. That combination points strongly to an **AV node-dependent reentrant arrhythmia**. (pubmed.ncbi.nlm.nih.gov)

Pathophysiology

The core mechanism in PSVT is **reentry**. In AVNRT, the AV node functionally behaves as if it has **two pathways**: a **fast pathway** and a **slow pathway**. A premature atrial impulse can find the fast pathway refractory, conduct down the slow pathway, then return retrograde through the recovered fast pathway, creating a self-sustaining loop. (pubmed.ncbi.nlm.nih.gov)

That circuit explains why AVNRT begins and ends abruptly. Once the loop is established, the ventricles are activated rapidly but usually through the normal His-Purkinje system, so the QRS remains **narrow** unless there is aberrancy. (pubmed.ncbi.nlm.nih.gov)

In **AVRT**, the reentrant loop uses an **accessory pathway** outside the AV node. In sinus rhythm, patients with Wolff-Parkinson-White may show **preexcitation**, classically a **delta wave**, reflecting early ventricular activation through that accessory tract; during orthodromic AVRT, however, the tachycardia is often still narrow-complex because ventricular activation proceeds down the AV node and back up the accessory pathway. (pubmed.ncbi.nlm.nih.gov)

**Adenosine** works because AV node-dependent PSVT depends on conduction through the AV node to keep the circuit alive. Electrophysiologic studies showed that adenosine **depresses AV nodal conduction** for a very brief period, which is enough to interrupt AV node-dependent reentry and restore sinus rhythm. (pubmed.ncbi.nlm.nih.gov)

From a Step 1 perspective, the pharmacology matters: adenosine activates **A1 receptors**, increases **K+ efflux**, causes **hyperpolarization**, and produces a **transient AV nodal block**. That mechanism is exactly why it is both **diagnostic** and **therapeutic** in PSVT. (pubmed.ncbi.nlm.nih.gov)

Clinical Presentation

Patients usually describe **abrupt palpitations** that start without warning and stop just as suddenly. They may also report **lightheadedness**, **dizziness**, or **mild chest discomfort**, especially while the rate remains rapid. (pubmed.ncbi.nlm.nih.gov)

The rhythm is typically **regular**, and many episodes are well tolerated in patients without structural heart disease. Still, the same tachycardia can produce **hypotension** or more obvious hemodynamic compromise in patients with less cardiovascular reserve, which is why stability always comes first in the emergency setting. (pubmed.ncbi.nlm.nih.gov)

Common triggers in teaching vignettes include **caffeine**, **alcohol**, and **emotional stress**. A helpful historical clue is that symptoms may improve with a **Valsalva maneuver** or another vagal maneuver, because increasing vagal tone slows AV nodal conduction and may interrupt the circuit. (pubmed.ncbi.nlm.nih.gov)

On ECG, PSVT classically appears as a **regular narrow-complex tachycardia**. In AVNRT, **P waves may be hidden**, and some tracings show a subtle **pseudo-R′ in V1**, an exam clue that strongly favors AVNRT over a sinus tachycardia or a clearly visible atrial rhythm. (pubmed.ncbi.nlm.nih.gov)

The following table summarizes the highest-yield comparison between the common AV node-dependent reentrant mechanisms described in PSVT. (pubmed.ncbi.nlm.nih.gov)

| Feature | AVNRT | AVRT (WPW-associated) | |---|---|---| | Mechanism | Reentry within or near the AV node using dual pathways | Reentry using an accessory pathway | | Typical ECG during episode | Narrow QRS; P waves often hidden | Often narrow QRS in orthodromic tachycardia | | Sinus-rhythm clue | Usually no preexcitation pattern | May show a delta wave in sinus rhythm | | Response to adenosine | Usually terminates | Terminates if the circuit depends on the AV node |

Diagnostic Approach

The first step is not memorizing a drug dose; it is deciding whether the patient is **stable or unstable**. If there is **hypotension**, **altered mental status**, or another sign of hemodynamic compromise, do not linger on prolonged bedside maneuvers—move to **cardioversion**. (pubmed.ncbi.nlm.nih.gov)

If the patient is stable, the key diagnostic test is an **ECG during the episode**. A regular narrow-complex tachycardia without clearly discernible P waves strongly supports PSVT, and a subtle pseudo-R′ in V1 points toward AVNRT. (pubmed.ncbi.nlm.nih.gov)

Adenosine can help diagnostically as well as therapeutically. In AV node-dependent reentry, transient AV nodal block often **terminates** the rhythm; if it does not terminate an atrial rhythm, it may still briefly expose atrial activity and clarify what the arrhythmia actually is. (pubmed.ncbi.nlm.nih.gov)

When the history suggests recurrent episodic palpitations but the office ECG is normal, the practical goal is to document the rhythm during symptoms and evaluate for a reentrant mechanism or an accessory pathway. Recurrent or severe episodes should prompt **electrophysiologic evaluation**, especially when preexcitation is suspected. (pubmed.ncbi.nlm.nih.gov)

Management & Prevention

In a **stable** patient, begin with **vagal maneuvers** such as the **Valsalva maneuver**. These increase vagal tone to the AV node and may terminate the rhythm without medication. (pubmed.ncbi.nlm.nih.gov)

If vagal maneuvers fail, the next key step is **rapid IV adenosine**. Clinical trials showed that adenosine rapidly terminates AV node-dependent PSVT, often within seconds, and its brief action is one reason it is so useful in the emergency setting. (pubmed.ncbi.nlm.nih.gov)

Adenosine is also high-yield because of its side effects. Patients may develop **brief flushing**, **chest discomfort**, or a transient sense of dyspnea, but these effects are usually short-lived because the drug’s action is so brief. (pubmed.ncbi.nlm.nih.gov)

If adenosine is contraindicated or not effective, alternatives include **verapamil** or **beta-blockers** in stable patients. In one multicenter trial, adenosine and verapamil showed similar overall efficacy for AV node-dependent PSVT, though adenosine acted more rapidly. (pubmed.ncbi.nlm.nih.gov)

In an **unstable** patient, proceed to **immediate synchronized cardioversion**. This is the management pivot that Step 2 CK questions test repeatedly: **stability first, rhythm mechanism second**. (pubmed.ncbi.nlm.nih.gov)

For recurrent or refractory episodes, **catheter ablation** of the responsible pathway is the definitive strategy. Slow-pathway ablation for AVNRT and accessory-pathway ablation for AVRT can eliminate the reentrant substrate rather than simply suppressing episodes after they begin. (pubmed.ncbi.nlm.nih.gov)

Long-term prevention also includes **avoiding triggers** such as caffeine or alcohol and, in selected patients, using **beta-blockers** or **nondihydropyridine calcium channel blockers** to reduce recurrences. The exact preventive plan depends on recurrence burden, tolerance of symptoms, and whether an ablation strategy is being pursued. (pubmed.ncbi.nlm.nih.gov)

High-Yield Differentials & Pitfalls

The most important differential is deciding whether the regular narrow-complex tachycardia represents **AVNRT**, **AVRT**, or **atrial tachycardia**. On exam questions, AVNRT is favored by **hidden P waves** or a **pseudo-R′ in V1**, while AVRT should make you look for **delta waves in sinus rhythm** that suggest an accessory pathway. (pubmed.ncbi.nlm.nih.gov)

A second major pitfall is forgetting that not every tachycardia should be treated the same way. In **WPW with preexcited atrial fibrillation**, **AV nodal blockers should be avoided**, because preferentially blocking the AV node may leave conduction to the ventricles dominated by the accessory pathway. In that setting, the classic exam answer is **procainamide** rather than an AV nodal blocker. (pubmed.ncbi.nlm.nih.gov)

Another pitfall is managing the tracing before managing the patient. A young patient with a regular narrow-complex tachycardia and normal blood pressure is a vagal-maneuver/adenosine patient; a patient with **hypotension** or **altered mental status** is a cardioversion patient, even if you have not fully sorted out the exact mechanism yet. (pubmed.ncbi.nlm.nih.gov)

A final high-yield association is prognosis. In structurally normal hearts, PSVT is often **benign and well tolerated**, but recurrent episodes can still disrupt quality of life and justify referral for definitive therapy. In patients with accessory pathways, the stakes rise because preexcited atrial fibrillation can produce very rapid ventricular rates. (pubmed.ncbi.nlm.nih.gov)

| Pitfall | Why it matters | Safer exam approach | |---|---|---| | Jumping to a drug before assessing stability | Unstable tachycardia needs immediate cardioversion | Check blood pressure and mental status first | | Missing WPW clues in sinus rhythm | Accessory pathways change management | Look for a delta wave between episodes | | Using AV nodal blockers in preexcited AF | May worsen ventricular conduction through the accessory pathway | Use procainamide in the classic vignette | | Forgetting definitive therapy | Recurrent PSVT is highly treatable | Refer for electrophysiology and possible ablation |

Exam Vignette

A 24-year-old woman presents with sudden palpitations that began while studying after several cups of coffee. Her heart rate is 190/min, blood pressure is 118/72 mm Hg, and ECG shows a **regular narrow-complex tachycardia** with no clearly visible P waves; a subtle **pseudo-R′ in V1** is noted. Vagal maneuvers do not terminate the rhythm. (pubmed.ncbi.nlm.nih.gov)

**Most likely diagnosis:** AV nodal reentrant tachycardia causing PSVT. (pubmed.ncbi.nlm.nih.gov)

**Best next step:** Rapid IV **adenosine** because she is **hemodynamically stable** and the rhythm is most consistent with an **AV node-dependent reentrant tachycardia**. (pubmed.ncbi.nlm.nih.gov)

**Reasoning:**

Key Takeaways

Keep Learning

To lock in PSVT for exams, keep asking yourself three questions whenever you see a tachycardia strip: **Is the patient stable? Is the rhythm narrow and regular? Does the arrhythmia appear AV node-dependent?** That sequence leads you to the right acute management choice quickly. (pubmed.ncbi.nlm.nih.gov)

A strong review plan is to practice three high-yield pattern recognitions:

If you want to deepen retention, pair the ECG pattern with the mechanism: **reentry through the AV node** explains why **AV nodal block** from vagal stimulation or adenosine stops the episode. That single concept links electrophysiology, ECG recognition, and bedside management into one durable framework. (pubmed.ncbi.nlm.nih.gov)

Read this article on CoreStepPrep